Sherif Badawy
Pediatric Hematology-Oncology · Chicago, ILNPI 1821355660
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $261,103 of the $328,697 with a category attached, or 79.4%. 20 manufacturers reported payments, led by Agios Pharmaceuticals, Inc. at 39.2% of the total. 2025 is the largest year on record at $120,831, more than ten times the $11,208 reported in 2019. Among pediatric hematology-oncology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 201 payments — averaging $1635.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Agios Pharmaceuticals, Inc.$129K
- Vertex$87K
- Chiesi USA, Inc.$63K
- X4 Pharmaceuticals, Inc.$15K
- Bioverativ Therapeutics Inc.$11K
- Sobi, Inc$8K
- plus $17K from 14 others
Across 9 payments — averaging $16,559 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bristol Myers Squibb$119K
- Pfizer$14K
- Apo-pharma Inc.$13K
- Novartis$4K
What the payments were for
- Consulting fees$261,10379%
- Speaking & faculty fees$46,05914%
- Travel & lodging$16,6075%
- Food & beverage$4,9281%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Agios Pharmaceuticals, Inc. | 61 | $128,909 |
| Vertex | 54 | $86,625 |
| Chiesi USA, Inc. | 37 | $62,872 |
| X4 Pharmaceuticals, Inc. | 5 | $14,843 |
| Bioverativ Therapeutics Inc. | 10 | $11,208 |
| Sobi, Inc | 10 | $7,706 |
| E.r. Squibb & Sons, L.L.C. | 1 | $4,152 |
| Genetix Biotherapeutics Inc | 3 | $2,800 |
| Tersera Therapeutics LLC | 4 | $2,196 |
| Global Blood Therapeutics, Inc. | 3 | $2,178 |
| Modernatx, Inc. | 2 | $2,125 |
| Halozyme Inc | 1 | $609 |
| ZOLL Medical Corporation | 1 | $599 |
| Sanofi | 1 | $550 |
| Melinta Therapeutics, LLC | 1 | $499 |
| Pfizer | 2 | $330 |
| Bristol Myers Squibb | 1 | $163 |
| Novo Nordisk | 2 | $152 |
| Emmaus Medical, Inc. | 1 | $142 |
| Novartis | 1 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$328,697 in reported general payments places this provider in the 95th percentile of 78 pediatric hematology-oncology providers in Illinois.
See all pediatric hematology-oncology providers in Illinois →
Other pediatric hematology-oncology in Chicago
- Alexis ThompsonChicago$1.6M
- Leonard ValentinoChicago$132K
- Susan CohnChicago$127K
- James LabelleChicago$88K
- Miriam BornhorstChicago$83K
- Loretta LiChicago$75K
- Sonali ChaudhuryChicago$53K
- Stewart GoldmanChicago$51K
- David JacobsohnChicago$38K
- Angela WaandersChicago$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.